Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India
01 juin 2021 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, June 1, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,...
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
13 avr. 2021 07h45 HE
|
Auris Medical AG
Clinical evaluation of AM-301 nasal spray in allergic rhinitis meets primary endpoint Extended protection achieved over several hoursPreliminary preclinical data suggest therapeutic utility post...
Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis
29 janv. 2021 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
01 déc. 2020 09h00 HE
|
Auris Medical AG
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001)Results suggest potential for AM-301 nasal spray to mitigate risk of Sars-CoV-2 infection Hamilton, Bermuda, December...
Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
20 nov. 2020 09h10 HE
|
Auris Medical AG
Hamilton, Bermuda, November 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring VistaGen Therapeutics Inc. CEO Shawn Singh
27 oct. 2020 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
OTC and Personal Care Trend Report 2020 Featuring Avida, GUM, Hello Bello, Oral-B, Sopharax, Vegamour
26 oct. 2020 05h33 HE
|
Research and Markets
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "OTC and Personal Care Trend Report 2020" report has been added to ResearchAndMarkets.com's offering. Looking at the impact of wellness on...
Auris Medical Launches Development of Drug-Free Nasal Spray for Protection against Airborne Pathogens and Allergens
08 sept. 2020 08h30 HE
|
Auris Medical AG
Development of AM-301 nasal spray initiated with aim of regulatory submission in 2021Key component of AM-301 shown to reduce SARS-CoV-2 viral infectious load in vitro by up to 99%Creation of dedicated...
Nasal Spray Market Size 2020: Global Industry Share Analysis, Future Demand & Growth Rate (CAGR +6.12%) to Witness High Demand Due to Increasing Cases of Allergic Rhinitis and Infections| ADAPT Pharma, Inc., Sandoz International GmbH, INNOVUS PHARMACEUTICALS, INC
03 sept. 2020 15h11 HE
|
Data Bridge Market Research
SAN FRANCISCO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Data Bridge Market Research published a new report, titled, “Nasal Spray Market Size 2020: Global Industry Share Analysis, Future Demand &...
Itonis, Inc. announces “Emesyl® Plus” homeopathic nasal spray containing Premium Hemp Oil
26 sept. 2018 14h11 HE
|
Itonis, Inc.
LAGUNA HILLS, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Itonis, Inc. (OTC PINKSHEETS: ITNS) Itonis, Inc. is pleased to announce Emesyl® Plus, a new revolutionary homeopathic nasal spray containing...